Proteomics International Laboratories Ltd (ASX:PIQ) Next-gen PromarkerD test system released for predicting Diabetic Kidney Disease
Proteomics International Laboratories Ltd (ASX:PIQ) Next-gen PromarkerD test system released for predicting DKD
Companies in the News
Biotech
Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Launched into the US at Major Diabetes Conference
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, proudly announces the initial US launch of its groundbreaking predictive test for diabetic kidney disease, PromarkerD, at the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago, Illinois.
Proteomics International Laboratories Ltd (ASX:PIQ) A Landmark in Non-Invasive Esophageal Cancer Diagnosis
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics is pleased to announce the publication of clinical validation results in the journal Proteomes showing its PromarkerEso blood test can diagnose esophageal adenocarcinoma with high accuracy.
Proteomics International Laboratories Ltd (ASX:PIQ) New Blood Test For Endometriosis Moves Closer to Market
Proteomics International Laboratories Ltd (ASX:PIQ) has unveiled landmark clinical data confirming its Promarker(R)Endo blood test as a highly accurate, non-invasive diagnostic tool for endometriosis.
Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerEndo Latest Results Presented at World Congress
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce another milestone in the development of its PromarkerEndo diagnostic test for endometriosis.
AFT Pharmaceuticals Limited (ASX:AFP) Sees Strong FY 26 as Revenue Reaches New Record
AFT Pharmaceuticals Limited (NSX:AFT) (ASX:AFP) today reports it has again achieved another year of record revenue with annual sales exceeding $200 million1 and it is now firmly focused on its revenue target of $300 million by the end of the 2027 financial year.
Ellis Martin Report: GT Biopharma Inc's (NASDAQ:GTBP) Michael Breen: Targeting Cancer Cells with a Natural Killer Based Immunotherapy
In this compelling episode of The Ellis Martin Report, host Ellis Martin engages in a powerful and enlightening conversation with Michael Breen, CEO and Managing Director of GT Biopharma Inc. (NASDAQ:GTBP).
Biotech Next Page▸
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
- NSX Limited (ASX:NSX) Company Update
- ASIC vs iSignthis Ltd and Nickolas John Karantzis
Oil Gas & Energy
- Beetaloo Energy Australia Limited (ASX:BTL) Commences Carpentaria-5H Hydraulic Stimulation Operations
- Empire Energy Group Ltd (ASX:EEG) Change of Name and ASX Code
- VIDEO: Empire Energy Group Limited (ASX:EEG) Shareholder Support Erupts as Gas Production Draws Closer
- State Gas Limited (ASX:GAS) Access Restored at Rolleston West Project Assets
- Empire Energy Group Ltd (ASX:EEG) Updated Investor Presentation
- Empire Energy Group Ltd (ASX:EEG) Appointment of Chief Financial Officer
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) Next-gen PromarkerD test system released for predicting Diabetic Kidney Disease
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Launched into the US at Major Diabetes Conference
- Proteomics International Laboratories Ltd (ASX:PIQ) A Landmark in Non-Invasive Esophageal Cancer Diagnosis
- Proteomics International Laboratories Ltd (ASX:PIQ) New Blood Test For Endometriosis Moves Closer to Market
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerEndo Latest Results Presented at World Congress
- AFT Pharmaceuticals Limited (ASX:AFP) Sees Strong FY 26 as Revenue Reaches New Record
Social Media
